Trials / Completed
CompletedNCT04327479
Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 728 (actual)
- Sponsor
- University Hospital, Essen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute myocardial injury) and chronic damage to the cardiovascular system. Therefore, cardiovascular protection may be necessary when treating patients with COVID-19 infection. This may especially be necessary in patients with cardiovascular diseases, risk factors, and co-medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Assessment of cardiovascular diseases and cardiovascular risk factors | At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication. |
Timeline
- Start date
- 2020-03-26
- Primary completion
- 2022-03-25
- Completion
- 2022-07-25
- First posted
- 2020-03-31
- Last updated
- 2022-11-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04327479. Inclusion in this directory is not an endorsement.